Clinical Transplants 2009 Individual Chapter Downloads
A Review of the Past 25 Years of Clinical Transplants.
A Review of the Past 25 Years of Clinical Transplants. Kaneku H, Terasaki PI.Clinical Transplan..
$0.00
A Summary of Bortezomib Use in Transplantation Across 29 Centers.
A Summary of Bortezomib Use in Transplantation Across 29 Centers. Everly MJ.Clinical Trans..
$0.00
Acute Rejection in a Highly Sensitized Lung Transplant Recipient with Pre-formed Donor-directed Anti-HLA Class II Antibodies: Role of Bortezomib Therapy.
Acute Rejection in a Highly Sensitized Lung Transplant Recipient with Pre-formed Donor-directed Anti..
$0.00
Altruistic Donation Through the Alliance for Paired Donation.
Altruistic Donation Through the Alliance for Paired Donation. Rees MA, Bargnesi D, Samy K, Reec..
$0.00
An Analysis of the OPTN/UNOS Liver Transplant Registry.
An Analysis of the OPTN/UNOS Liver Transplant Registry. Waki K, Tamura S, Sugawara Y, Yamashiki..
$0.00
Antihumoral Rejection Therapy by Proteasome Inhibitor Bortezomib: A Case Series.
Antihumoral Rejection Therapy by Proteasome Inhibitor Bortezomib: A Case Series. Lachmann N, Sc..
$0.00
Bortezomib Affects the Function of Human B Cells: Possible Implications for Desensitization Protocols.
Bortezomib Affects the Function of Human B Cells: Possible Implications for Desensitization Protocol..
$0.00
Bortezomib Alone Fails to Decrease Donor Specific Anti-HLA Antibodies: 4 Case Reports.
Bortezomib Alone Fails to Decrease Donor Specific Anti-HLA Antibodies: 4 Case Reports. Sberro-S..
$0.00
Bortezomib as a Rescue Therapy for Hyperacute and Multi-Drug Resistant Mixed Acute Rejection After Kidney Transplantation.
Bortezomib as a Rescue Therapy for Hyperacute and Multi-Drug Resistant Mixed Acute Rejection After K..
$0.00
Bortezomib as Therapy for Mixed Humoral and Cellular Rejection: Should It Be First Line?
Bortezomib as Therapy for Mixed Humoral and Cellular Rejection: Should It Be First Line? Lee I,..
$0.00
Bortezomib Does Not Reduce Abo-Isoagglutinin Titers and May Not Be Useful for Abo-incompatible Transplant Desensitization.
Bortezomib Does Not Reduce Abo-Isoagglutinin Titers and May Not Be Useful for Abo-incompatible Trans..
$0.00
Bortezomib for Acute Humoral Rejection in Two Repeat Transplant Recipients.
Bortezomib for Acute Humoral Rejection in Two Repeat Transplant Recipients. Hardinger KL, Alfor..
$0.00
Bortezomib for Antibody Mediated Rejection Treatment: Experience at the Instituto Nacional De Ciencias Médicas Y Nutrición Salvador Zubirán in Mexico City.
Bortezomib for Antibody Mediated Rejection Treatment: Experience at the Instituto Nacional De Cienci..
$0.00
Bortezomib for Refractory Antibody-mediated Cardiac Allograft Rejection.
Bortezomib for Refractory Antibody-mediated Cardiac Allograft Rejection. Eckman PM, Thorsgard M..
$0.00
Bortezomib for the Treatment of De Novo HLA Antibody-related Antibody Mediated Rejection.
Bortezomib for the Treatment of De Novo HLA Antibody-related Antibody Mediated Rejection. Al Me..
$0.00
Bortezomib in Kidney Transplant Desensitization: A Case Report.
Bortezomib in Kidney Transplant Desensitization: A Case Report. Raghavan R, Jeroudi A, Achkar K..
$0.00
Bortezomib in Kidney Transplant Recipients with Antibody Mediated Rejection: Three Case Reports.
Bortezomib in Kidney Transplant Recipients with Antibody Mediated Rejection: Three Case Reports.&nbs..
$0.00
Bortezomib in Lung Transplantation: A Promising Start.
Bortezomib in Lung Transplantation: A Promising Start. Neumann J, Schio S, Tarrasconi H, Bortol..
$0.00
Bortezomib in the Treatment of Antibody-mediated Rejection--A Report of 3 Cases.
Bortezomib in the Treatment of Antibody-mediated Rejection--A Report of 3 Cases. Mai HL, Cesbro..
$0.00
Bortezomib Rescue in Refractory Acute Humoral Rejection--Report of a Case.
Bortezomib Rescue in Refractory Acute Humoral Rejection--Report of a Case. Shapiro R, Basu A, Z..
$0.00
Bortezomib Successfully Reduces Monoclonal Serum Free Light Chain Levels in a Patient with Recurrent Myeloma and Cast Nephropathy in the Renal Transplant.
Bortezomib Successfully Reduces Monoclonal Serum Free Light Chain Levels in a Patient with Recurrent..
$0.00
Bortezomib Use in Chronic Antibody-mediated Allograft Dysfunction: A Report of Three Cases.
Bortezomib Use in Chronic Antibody-mediated Allograft Dysfunction: A Report of Three Cases. Coo..
$0.00
Bortezomib-based Treatment of Antibody Mediated Rejection in Pancreas Allograft Recipients.
Bortezomib-based Treatment of Antibody Mediated Rejection in Pancreas Allograft Recipients. Gov..
$0.00
Case Presentations on Two Patients Who Received Bortezomib for Antibody Mediated Rejection at BIDMC.
Case Presentations on Two Patients Who Received Bortezomib for Antibody Mediated Rejection at BIDMC...
$0.00
Clonal Deletion Using Total Lymphoid Irradiation with no Maintenance Immunosuppression in Renal Allograft Recipients.
Clonal Deletion Using Total Lymphoid Irradiation with no Maintenance Immunosuppression in Renal Allo..
$0.00
Desensitization Protocol Using Bortezomib for Highly Sensitized Patients Awaiting Heart or Lung Transplants.
Desensitization Protocol Using Bortezomib for Highly Sensitized Patients Awaiting Heart or Lung Tran..
$0.00
Epitopes of HLA-A, B, C, DR, DQ, DP and MICA Antigens.
Epitopes of HLA-A, B, C, DR, DQ, DP and MICA Antigens. El-Awar N, Terasaki PI, Cai J, Deng CT, ..
$0.00
Exchange-donor Renal Transplantation.
Exchange-donor Renal Transplantation. Huh KH, Kim HJ, Jeon KO, Kiml BS, Kim YS, Park K.Clinical..
$0.00
Four Decades of the Kidney Transplantation Program at the Institute Nacional De Ciencias Médicas y Nutrición Salvador Zubirán in Mexico City.
Four Decades of the Kidney Transplantation Program at the Institute Nacional De Ciencias Médicas y N..
$0.00
Graft Survival Trends in Kidney Transplants: an Analysis of the UNOS Database.
Graft Survival Trends in Kidney Transplants: an Analysis of the UNOS Database. Goh A.Clinical T..
$0.00
Heart Transplantation in the United States from 1998 to 2008.
Heart Transplantation in the United States from 1998 to 2008. Ravindranath MH, Everly MJ.Clinic..
$0.00
Indiana University Kidney Transplant Program: Overview and Summary of the Last 1022 Kidney Alone Transplants with at Least 1 Year Follow-up.
Indiana University Kidney Transplant Program: Overview and Summary of the Last 1022 Kidney Alone Tra..
$0.00
Indications for and Results of Liver Retransplantation.
Indications for and Results of Liver Retransplantation. Moya A, Torres-Quevedo R, San Juan F, M..
$0.00
Intestinal and Multivisceral Transplantation at Indiana University: 6 Years' Experience with 100 Cases.
Intestinal and Multivisceral Transplantation at Indiana University: 6 Years' Experience with 100 Cas..
$0.00
Intestinal and Multivisceral Transplantation at the University of Miami.
Intestinal and Multivisceral Transplantation at the University of Miami. Selvaggi G, Nishida S,..
$0.00
Intestine and Multivisceral Transplantation in the United States: A Report of 20-year National Registry Data (1990-2009).
Intestine and Multivisceral Transplantation in the United States: A Report of 20-year National Regis..
$0.00
Is Pancreas Transplantation Getting Old? Single-center Experience in an Aging Society.
Is Pancreas Transplantation Getting Old? Single-center Experience in an Aging Society. Viebahn ..
$0.00
Kidney Transplantation at the University of Pennsylvania: 1998-2008.
Kidney Transplantation at the University of Pennsylvania: 1998-2008. Porrett PM, Kamoun M, Pars..
$0.00
Lung and Heart-lung Transplantation at University of Pittsburgh: 1982-2009.
Lung nd Heart-lung Transplantation at University of Pittsburgh: 1982-2009. Thacker J, Toyoda Y...
$0.00
Lung Transplantation at Duke University.
Lung Transplantation at Duke University. Hartwig MG, Snyder LD, Finlen-Copeland A, Lin SS, Zaas..
$0.00
Maximizing Utilization of Reported Donor Lungs in Eurotransplant: Impact of the Rescue Allocation Policy on Utilization Rates.
Maximizing Utilization of Reported Donor Lungs in Eurotransplant: Impact of the Rescue Allocation Po..
$0.00
Modulation of Antibody Response in a Sensitized Patient with Ongoing Antibody-mediated Injury.
Modulation of Antibody Response in a Sensitized Patient with Ongoing Antibody-mediated Injury. ..
$0.00
On Chain Lengths, Domino-paired and Unbalanced Altruistic Kidney Donations.
On Chain Lengths, Domino-paired and Unbalanced Altruistic Kidney Donations. de Klerk M, Zuidema..
$0.00
Pancreas Transplantation in the United States: an Analysis of the UNOS Registry.
Pancreas Transplantation in the United States: an Analysis of the UNOS Registry. Everly MJ.Clin..
$0.00
Proteasome Inhibition for Recipient Desensitization? A Report of Two Sensitized Kidney Transplant Candidates Subjected to Bortezomib Treatment.
Proteasome Inhibition for Recipient Desensitization? A Report of Two Sensitized Kidney Transplant Ca..
$0.00
Removal of Physiologic Corticosteroid Doses Results in HLA Antibody Appearance and Allograft Dysfunction in Patients Transplanted Under a Clonal Deletion Protocol.
Removal of Physiologic Corticosteroid Doses Results in HLA Antibody Appearance and Allograft Dysfunc..
$0.00
Report from the National Transplantation Pregnancy Registry (NTPR): Outcomes of Pregnancy After Transplantation.
Report from the National Transplantation Pregnancy Registry (NTPR): Outcomes of Pregnancy After Tran..
$0.00
Rescue Therapy for Early Antibody Mediated Rejection with a Proteasome Inhibitor: A Case Report.
Rescue Therapy for Early Antibody Mediated Rejection with a Proteasome Inhibitor: A Case Report.&nbs..
$0.00
Successful Desensitization in a Crossmatch Positive Living-related Kidney Transplant Recipient Using a Bortezomib-based Protocol.
Successful Desensitization in a Crossmatch Positive Living-related Kidney Transplant Recipient Using..
$0.00
Successful Treatment with Bortezomib of a Refractory Humoral Rejection of the Intestine After Multivisceral Transplantation.
Successful Treatment with Bortezomib of a Refractory Humoral Rejection of the Intestine After Multiv..
$0.00
The Fate of Anti-HLA Antibody Among Renal Transplantation Recipients Treated with Bortezomib.
The Fate of Anti-HLA Antibody Among Renal Transplantation Recipients Treated with Bortezomib.&n..
$0.00
The National Kidney Registry: Transplant Chains--Beyond Paired Kidney Donation.
The National Kidney Registry: Transplant Chains--Beyond Paired Kidney Donation. Veale J, Hil G...
$0.00
Use of Bortezomib as Adjunctive Therapy for Densensitization in Combined Heart and Kidney Transplantation--A Case Report.
Use of Bortezomib as Adjunctive Therapy for Densensitization in Combined Heart and Kidney Transplant..
$0.00
Use of Bortezomib for Prevention and Treatment of Rejection in Sensitized Patients.
Use of Bortezomib for Prevention and Treatment of Rejection in Sensitized Patients. Hartono C, ..
$0.00
Use of Bortezomib for Treatment of Antibody Medicated Rejection in Kidney Transplant Recipients--Case Report.
Use of Bortezomib for Treatment of Antibody Medicated Rejection in Kidney Transplant Recipients--Cas..
$0.00